Neoadjuvant Chemotherapy With Myocet/Taxotere/Herceptin for HER2 Positive Breast Cancer Patients
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Myocet|DRUG: Taxotere|DRUG: Herceptin
Sponsor: Spanish Breast Cancer Research Group
Collaborators: Cephalon|Sanofi|Hoffmann-La Roche|Amgen